Trade Summary

3 days ago, Lawlor Sally Bridget, serving as Chief Financial Officer at Quoin Pharmaceuticals, Ltd. (QNRX), purchased 10,244 shares at $4.88 per share, for a total transaction value of $49,990.72. Following this transaction, Lawlor Sally Bridget now holds 10,684 shares of QNRX.

This purchase represents a 2328.18% increase in Lawlor Sally Bridget's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, August 31, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, September 2, 2026 (accepted Sep 1, 9:39 PM ET), 2 days after the trade was made.

Quoin Pharmaceuticals, Ltd. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.